Futures contracts on the DAX (DE40) are down more than 0.7% today, as sentiment across European equity markets reflects increased investor caution and profit-taking following recent gains. The steepest losses are seen in Spain’s IBEX futures (SPA35), falling nearly 1.5%. In sector terms, banking and pharmaceuticals are underperforming across Europe, with shares of Novo Nordisk (NOVOB.DK) down more than 2%.
- In Germany, the defense sector stands out with notable gains. Shares of defense stocks RENK Group and Hensoldt are up nearly 4%, while Rheinmetall is gaining around 2%. In contrast, Lufthansa and Commerzbank shares are losing between 3% and 4%.
- Among the top performers on the German market today are Steico and Befesa, leading the list of gainers.
- According to AFP, a meeting is scheduled today between Donald Trump and Ukrainian President Volodymyr Zelenskyy.
DE40 (H1 Interval)
DAX futures (DE40) are pulling back by over 0.7% and are currently testing the 200-period exponential moving average (EMA) on the hourly chart. Selling volume is clearly dominant today.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appSource: xStation5
Rheinmetall Shares Rebound
Shares of German defense giant Rheinmetall are rising over 2% today, climbing above €1,720 and rebounding above the 50-day exponential moving average (EMA50) on the daily chart. The stock currently trades around 8% below its all-time highs.
Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
